Article type
Year
Abstract
Background:
investigators increasingly rely on patient-reported outcomes (PRO) as key end points in clinical trials, meta-analyses, and clinical practice guidelines. The interpretation of the magnitude of treatment effects on PRO measures (PROMs), however, presents challenges. The most common reference point for the interpretation of PROMs is the minimal important difference (MID), which provides a measure of the smallest change in a PROM that patients experience as important. Understanding how to evaluate the credibility of MIDs and apply these estimates to enhance interpretability of results from PROMs will ensure the presentation of such data in systematic reviews and guidelines is trustworthy and optimally interpretable.Objectives
1) Review the use of MIDs in enhancing interpretability of PROMs in systematic reviews
2) Introduce an instrument for evaluating the credibility of MIDs and apply it to a sample of studies
3) Present a resource for identifying anchor-based MIDs for PROMs: the MID inventory
4) Help participants apply presentation approaches relying on the MID to make PROMs more interpretable in systematic reviews